Logan Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Logan Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89M	Buy	+3,769	New	+$1.81M	0.07%	177
2026 Q1	–	Sell	-362	Closed	-$196K	–	504
2025 Q4	$210K	Hold	362	–	–	0.01%	272
2025 Q3	$176K	Hold	362	–	–	0.01%	278
2025 Q2	$147K	Hold	362	–	–	0.01%	274
2025 Q1	$180K	Sell	362 -29	-7%	-$15.7K	0.01%	284
2024 Q4	$203K	Buy	391 +3	+0.8%	+$1.65K	0.01%	283
2024 Q3	$240K	Buy	388 +6	+2%	+$3.55K	0.01%	278
2024 Q2	$211K	Hold	382	–	–	0.01%	283
2024 Q1	$222K	Sell	382 -13	-3%	-$7.29K	0.01%	280
2023 Q4	$210K	Sell	395 -120	-23%	-$58.1K	0.01%	287
2023 Q3	$261K	Sell	515 -1	-0.2%	-$533	0.01%	270
2023 Q2	$269K	Sell	516 -107	-17%	-$57.7K	0.01%	267
2023 Q1	$359K	Sell	623 -20	-3%	-$11.3K	0.02%	267
2022 Q4	$354K	Hold	643	–	–	0.02%	263
2022 Q3	$326K	Sell	643 -23	-3%	-$12.9K	0.02%	257
2022 Q2	$362K	Sell	666 -16	-2%	-$8.81K	0.02%	257
2022 Q1	$403K	Hold	682	–	–	0.02%	259
2021 Q4	$455K	Buy	682 +228	+50%	+$142K	0.02%	258
2021 Q3	$259K	Buy	454 +23	+5%	+$12.6K	0.01%	279
2021 Q2	$217K	Buy	431 +20	+5%	+$9.44K	0.01%	280
2021 Q1	$188K	Buy	+411	New	+$196K	0.01%	281

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Logan Capital Management's TMO Position: Q2 2026 in Review

Logan Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 3,769 shares worth $1.89M. The stake represents 0.07% of the portfolio and ranks #177 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in TMO as recently as Q4 2025.

Logan Capital Management first reported a position in TMO in Q1 2021 and has held it in 21 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Logan Capital Management held 3,769 shares of Thermo Fisher Scientific worth $1.89M as of Q2 2026.
Thermo Fisher Scientific was a new Logan Capital Management position in Q2 2026.
Thermo Fisher Scientific made up 0.07% of Logan Capital Management's portfolio in Q2 2026, its #177 holding.
Logan Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 21 quarters since.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.